Nanox is an innovative medical imaging technology company developing the next generation of X-ray emitters based on groundbreaking nanotechnology.
Nanox is planning mass deployment of imaging systems. Our goal is to drive early detection preventive healthcare as a new standard of care.
Nanox was founded in 2016 by Ran Poliakine and Hitoshi Masuya. The company is headquartered in Israel.
The Nanox System is composed of the Nanox.Arc, a novel digital X-ray device and the Nanox.Cloud, a companion cloud-based software that will be designed to provide an end-to-end medical imaging service, that is expected to include image repository, radiologist matching, online and offline diagnostics review and annotation.
The Nanox.Cloud is being designed to provide an end-to-end medical imaging service, that covers AI analysis and more. The Nanox System is designed to enable medical screening as a service to improve the accessibility and affordability of early-detection services worldwide.
Nanox is backed by Foxconn, Fujifilm, A-Labs Advisory and Finance Ltd, SK Telecom, and others. The company added another $59M to its Series B on Jul 28, 2020. Which comes on the back of its $25M to the round in June 2020 to make the round total to $51M. With another $59M, the company has its Series B total to $110M. Nanox now has a total raised to $139M to date. Nanox went public on Aug 21, 2020 (trading as NNOX), where the company raised $165.2M, with $1B IPO valuation.